Who owns Progenics Pharmaceuticals?

Key details on Progenics Pharmaceuticals (Ticker: PGNX)

Who owns Progenics Pharmaceuticals?

Is PGNX a good stock to own? Find out who bought Progenics Pharmaceuticals, who sold Progenics Pharmaceuticals (PGNX) stock, and who holds a large position in Progenics Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 13.55M $55.42M March 31, 2014
Baker Bros. Advisors 4.45M $18.20M March 31, 2014
FMR 4.41M $18.02M March 31, 2014
Broadfin Capital 4.00M $21.32M Dec. 31, 2013
BlackRock Fund Advisors 2.76M $11.29M March 31, 2014
BlackRock Institutional Trust Company, N.A. 2.37M $9.67M March 31, 2014
Tudor Investment Corporation 2.34M $9.58M March 31, 2014
Vanguard 1.86M $7.59M March 31, 2014
Wellington Management Company 1.55M $6.32M March 31, 2014
Highland Capital Management 1.38M $5.66M March 31, 2014
Deerfield Management Company 1.04M $5.60M March 31, 2013
STATE STREET CORPORATION 995914 $4.07M March 31, 2014
Phocas Financial 805595 $3.29M March 31, 2014
NORTHERN TRUST 788855 $3.23M March 31, 2014
Taconic Capital Advisors 785982 $3.21M March 31, 2014
MORGAN STANLEY 762426 $3.12M March 31, 2014
DIMENSIONAL FUND ADVISORS 708064 $2.90M March 31, 2014
Franklin Resources 636816 $2.60M March 31, 2014
Jay G. Goldman 615000 $3.36M Dec. 31, 2010
Sandgrain Advisors 600000 $3.71M March 31, 2011
Kingdon Capital Management 580000 $2.58M June 30, 2013
D. E. Shaw & Co 575094 $2.89M Sept. 30, 2013
Inves 568708 $5.56M June 30, 2012

Who sold Progenics Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Perceptive Advisors March 31, 2011 585061 $3.62M